SignPath Pharma, Inc. — Form D/A

SignPath Pharma, Inc. of QUAKERTOWN, PA, a company, filed a Form D amendment with the SEC on 2012-05-04. The offering totals $3.0M, of which $1.3M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
Arthur D BollonDirectorQuakertown, PA
Jack D LevineDirectorQuakertown, PA
Meyers D Associates, L.P.PromoterNew York, NY
Robert SegusoDirectorSandy, UT
Robert SegusoExecutive OfficerSandy, UT
Peter SordilloExecutive OfficerSandy, UT
Arthur Ballon, Ph.DDirectorSandy, UT
Arthur Ballon, Ph.DExecutive OfficerSandy, UT
Kai LarsonDirectorSandy, UT
Kai LarsonExecutive OfficerSandy, UT
Timothy TouloukianExecutive OfficerSandy, UT
Robert P SegusoDirectorSandy, UT
Robert P SegusoExecutive OfficerSandy, UT
Timothy P ToloukianExecutive OfficerSandy, UT
Peter P SordilloExecutive OfficerSandy, UT
Arthur P Bollon, Ph.DDirectorSandy, UT
Beth P HechtDirectorSandy, UT
Robert P SagusoDirectorSandy, UT
Jack P Levine, CPADirectorSandy, UT
Kai P Larson, JDExecutive OfficerCenter Valley, PA
Lawrence D HelsonDirectorCenter Valley, PA
Lawrence D HelsonExecutive OfficerCenter Valley, PA
None P Meyers Associates, L.P.PromoterNew York, NY
N/A P Meyers Associates, L.P.PromoterNew York, NY
Arthur P BollonDirectorQuakertown, PA

Other filings by this issuer (11)

FiledFormOfferingSold
2021-05-12D$11.0M$1.6M
2020-08-28D$10.0M$525K
2017-12-18D$5.0M$235K
2016-07-15D$5.0M$245K
2016-01-27D/A$3.0M$2.4M
2014-11-26D$5.0M$320K
2014-06-05D/A$5.0M$4.4M
2013-03-22D$5.0M$1.0M
2011-10-04D$3.0M$580K
2010-06-01D$2.7M$25K
2009-03-05D$1.0M

More